NYXH - Nyxoah SA Long-Term Debt Volume

Graphic logo of Nyxoah S.A (NYXH)

This chart of the long-term liability value for Nyxoah S.A. (NYXH) is recorded at 0.04. Nyxoah S.A. (NYXH) develops Genio neurostimulators, where massive trial expenditures are followed by low-cost mass production of chips. High patent barriers and FDA certification protect the business from competitors. The innovative micro-implant, which targets the tongue nerves, relieves patients of sleep apnea without the use of bulky equipment.

NYXH Nyxoah S.A. Company Long-Term Debts (07/04/2022 - 11/01/2026)

Nyxoah, S.A. - analytical breakdowns and key metrics (NYXH)

- share price and expert price forecast:
Share Price nyxoah.com|NYXH - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Nyxoah S.A.|NYXH - Enterprise Value
- balance sheet equity data:
Accounting Value per Share Nyxoah S.A.|NYXH - Book Capitalization|Market Capitalization to Book Value Ratio nyxoah.com|NYXH - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Nyxoah S.A.|NYXH - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Nyxoah S.A|NYXH - Company Aggregate Debts|Debts to Net Assets Nyxoah S.A.|NYXH - Company Long-Term Debt|Company Short-Term Indebtedness Nyxoah S.A.|Interim Coverage Ratio nyxoah.com
- earnings and multiples data:
NYXH - Net Income
Summary company analytics:NYXH nyxoah.com
Manufactured products of Nyxoah S.A

Long-term debt reflects the aggregate of obligations with maturities exceeding twelve months, determining the issuer's financial stability and debt load. By analyzing the trajectory of the issuer's long-term liabilities, an investor assesses the company's ability to service loans without compromising liquidity. The current value of 0.04 captures the volume of raised capital. For Nyxoah S.A. (NYXH), such loans are critical for financing implant expansion amid a deficit of operating profit.

Competitors of Nyxoah S.A. (NYXH)

ISRG: Company Long-Term Indebtedness|Danaher - Company Long-Term Debts|Long-Term Debt Volume BD BDX|STE: Company Long-Term Debts|Company Long-Term Liabilities West Pharma Corp|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts masimo.com|Company Long-Term Debt Stevanato Group (STVN)|Company Long-Term Debt TFX (Teleflex Inc.)|Merit Medical Systems Inc - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings NVST|ICU Medical, Inc. - Company Long-Term Debts|Long-Term Debt Volume dentsplysirona.com XRAY|LeMaitre Vascular (LMAT) - Company Long-Term Debt|Company Long-Term Indebtedness ATRC|Company Long-Term Debt STAAR Surgical Corp|niagenbioscience.com (NAGE) - Long-Term Debt Volume|Company Long-Term Liabilities ZIMV (ZimVie Inc.)|Amount of Long-Term Liabilities ANGO|Company Long-Term Debt Cerus CERS|Company Long-Term Loans and Borrowings TKNO|MGRM: Company Long-Term Liabilities|STSS - Company Long-Term Debts|infusystem.com (INFU) - Company Long-Term Debt|Company Long-Term Liabilities utahmed.com|KRMD (KORU Medical Systems, Inc.) - Company Long-Term Debts|Long-Term Debt Microbot Medical, Inc. MBOT|Company Long-Term Debt Pro-Dex Corp (PDEX)|Zentek Corp - Company Long-Term Indebtedness|Elutia Inc. - Company Long-Term Liabilities|Amount of Long-Term Liabilities MLSS (milestonescientific.com)|NXGL - Company Long-Term Debt|Long-Term Debt Volume Retractable Technologies RVP|Harvard Bioscience, Inc. (HBIO) - Company Long-Term Debt|Company Long-Term Indebtedness FEMY|Company Long-Term Liabilities MHUA|Long-Term Debt Predictive Oncology Corp POAI|Company Long-Term Liabilities CJMB (Callan JMB Inc)|Atrion Corp. - Company Long-Term Indebtedness|Company Long-Term Debt NeuroMetrix Corp NURO